Showing posts from October, 2023

October's COVID-19 Impact

On October 13, 2023, the golfing world lost an eleven-time PGA Tour winner Andy Bean. He was 70. His demise came six weeks after undergoing a double-lung transplant to address severe lung damage caused by a battle with COVID-19.  Born on March 13, 1953, Thomas Andrew Bean spent his formative years on the picturesque Jekyll Island, Georgia, before his family relocated to Lakeland, Florida. The move was inspired by his father Tommy's passion for golf, which led to the development of a golf course in Lakeland. Andy Bean's connection to the sport grew stronger as he went on to attend the University of Florida, where he played alongside teammates Gary Koch, Woody Blackburn, and Phil Hancock, helping the Gators secure the 1973 NCAA Championship.  Bean turned professional in 1975, embarking on a journey that would establish him as one of the PGA Tour's most consistent performers. Standing at an impressive 6-foot-4, Bean even gained notoriety for an incident where he "wrestled

Polyradiculoneuropathy after breakthrough COVID-19

In late July 2021, a 67-year-old woman vaccinated with Sinopharm COVID-19 vaccine (inactivated virus) presented a unique and challenging medical case that underscores potential neurological consequences of both infection and vaccination.  The patient's journey began with the onset of common COVID-19 symptoms: fever, myalgia, mild dyspnea, headache, and a non-productive cough. She had no pre-existing medical conditions. Upon her initial evaluation, her vital signs were within a relatively stable range, with the exception of a slightly decreased oxygen saturation (SpO2) of 91%. Physical examination did not reveal any significant findings. Her positive SARS-CoV-2 polymerase chain reaction test prompted further investigation, given the mild dyspnea and decreased SpO2. A chest computed tomography scan revealed peripheral consolidation and ground glass opacities, typical of COVID-19 pneumonia. Treatment commenced with Dexamethasone and Remdesivir alongside supplemental oxygen. Over the